Livongo Buys Behavioral Health Firm In Multimillion Dollar Deal, Plans To Hire 300-500 People
Livongo, which developed a digital platform for managing chronic conditions, announced Jan. 30 it acquired myStrength, a Denver-based digital behavioral health company. The company didn’t disclose financial details, but Livongo's executive chairman Glen Tullman told Medtech Insight the acquisition cost was in the "tens of millions of dollars."
You may also be interested in...
Innovator Spotlight: Innovation Through Partnerships Is In Omron Healthcare's Blood
This year, Omron Healthcare launched its new HeartGuide smartwatch and the first FDA-cleared blood pressure monitor with EKG capability. Medtech Insight sat down with Omron's CEO Ranndy Kellogg to learn about upcoming plans.
ACC Results Recap Part III: RADIANCE-HTM SOLO Results Support ReCor’s Renal Denervation System
Medtech Insight's Results Recap is a regular feature covering the major device trial results compiled by MedDeviceTracker. This is the third of three Results Recaps covering trial data presented at the American College of Cardiology Scientific Sessions in New Orleans, March 16-18, including the final results of the MOMENTUM 3 trial of Abbott’s HeartMate 3 left-ventricular assist device and six-month results from the RADIANCE-HTN SOLO trial of ReCor’s Paradise renal denervation system, and more. Check out Part I and Part II of our ACC Results Recap.
Livongo Names Zane Burke New CEO; Jennifer Schneider Becomes President
Zane Burke is the new CEO of Livongo Health, the applied health signals company announced Dec. 18. Burke previously spent five years as president of health IT company Cerner Corp. Livongo also announced that Chief Medical Officer Jennifer Schneider has been promoted to president, overseeing product, data science, software engineering, marketing, and clinical operations.